Entrada Therapeutics, Inc. (TRDA)
6.31
+0.27
(+4.47%)
USD |
NASDAQ |
May 21, 16:00
6.50
+0.19
(+3.01%)
After-Hours: 19:59
Entrada Therapeutics Research and Development Expense (TTM) : 137.56M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.891B |
| Tyra Biosciences, Inc. | 110.89M |
| Biogen, Inc. | 1.607B |
| Catalyst Pharmaceuticals, Inc. | 11.48M |
| XOMA Royalty Corp. | 0.468M |